We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Adaptimmune Announces Opening of Phase I/II Clinical Trial for Metastatic Melanoma

News   Jun 20, 2011

 
Adaptimmune Announces Opening of Phase I/II Clinical Trial for Metastatic Melanoma
 
 
 

RELATED ARTICLES

Limitations of Health Reports From Direct-to-Consumer Genetic Tests Are Identified

News

According to study findings presented at the American Society of Human Genetics (ASHG) 2019 Annual Meeting, health reports from direct-to-consumer (DTC) genetic tests that adopt a limited variant screening approach are producing clinically false-negative results.

READ MORE

Dementia Associated With Altered Immune System

News

Recent research has revealed increased inflammatory activity in some patients with frontotemporal dementia.

READ MORE

Harmful Gene Interactions Trigger Rare Form of GI Tumor

News

The "breakdown" of the normal 3D shape of DNA enables harmful interactions to form between genes in a rare type of gastrointestinal stromal tumors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE